Venture Capital Investors

Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA is a VC investing group that helps tech companies with financing and expertise.

Venture Investor Overview

Venture Investor
Hyloris Pharmaceuticals SA
Status
InActive
Investor Type
Venture Capital
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Stijn Rompay
Title
Chief Executive Officer
Mailing Address
New address as from September, 1st 2022 HQ: Boulevard Patience et Beaujonc N°3/1
Liège, 4000
Belgium
Email Address

Background Information

Overview
Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer advantages compared to available alternatives, to address the underserved medical needs of patients, hospitals, physicians, payors, and other stakeholders in the healthcare system. Its portfolio spans three areas of focus IV Cardiovascular, Other Reformulations, and Established Market (high-barrier generics).
Profile
Hyloris Pharmaceuticals SA LinkedIn Company Profile
Social Media
Hyloris Pharmaceuticals SA Company Twitter Account
Company News
Hyloris Pharmaceuticals SA News
Facebook
Hyloris Pharmaceuticals SA on Facebook
YouTube
Hyloris Pharmaceuticals SA on YouTube
Last Transaction
9/6/2022

Transaction History

Our records indicate that Hyloris Pharmaceuticals SA invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/6/2022
$17,450,000

 


Investor Contacts

Title
Name
Email & Social
Chief Operating Officer
Dietmar Aichhorn
  Dietmar Aichhorn LinkedIn Profile  Dietmar Aichhorn Twitter Account  Dietmar Aichhorn News  Dietmar Aichhorn on Facebook
Co-Founder
Thomas Jacobsen
  Thomas Jacobsen LinkedIn Profile  Thomas Jacobsen Twitter Account  Thomas Jacobsen News  Thomas Jacobsen on Facebook
Chief Executive Officer
Stijn Rompay
  Stijn Rompay LinkedIn Profile  Stijn Rompay Twitter Account  Stijn Rompay News  Stijn Rompay on Facebook
Chief Financial Officer
Jean Vandebroek
  Jean Vandebroek LinkedIn Profile  Jean Vandebroek Twitter Account  Jean Vandebroek News  Jean Vandebroek on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Hyloris Pharmaceuticals SA has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Hyfinity Investments | Hype.eth

 

Share this article

 


About Our Venture Capital Investor Database

This venture capital firm data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary